Clinical Trial Update: Study of KN046 With Chemotherapy in First Line Advanced NSCLC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for KN046 in combination with chemotherapy as first-line treatment for advanced non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• KN046

Snippet

Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN